124 related articles for article (PubMed ID: 7875443)
1. [Adjuvant treatment of endocrine digestive tumors].
Ruszniewski P
Gastroenterol Clin Biol; 1994; 18(8-9):737-8. PubMed ID: 7875443
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of digestive neuroendocrine tumors].
Rougier P; Toma C; Fabri MC; Ducreux M
Ann Gastroenterol Hepatol (Paris); 1995; 31(2):117-20. PubMed ID: 7618833
[No Abstract] [Full Text] [Related]
3. Systemic chemotherapy of advanced digestive neuroendocrine tumours.
Rougier P; Ducreux M
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S202-6. PubMed ID: 10604131
[TBL] [Abstract][Full Text] [Related]
4. [The Sandostatin treatment of digestive carcinoid tumors].
Varas MJ; Marcillas J; Barrios P
Rev Clin Esp; 1993 Feb; 192(3):147. PubMed ID: 8465051
[No Abstract] [Full Text] [Related]
5. [Adjuvant treatments in digestive cancers. General principles].
Gérard JP; Trillet-Lenoir V; Thalabard JC
Gastroenterol Clin Biol; 1994; 18(8-9):710-3. PubMed ID: 7875438
[No Abstract] [Full Text] [Related]
6. [New medical therapy of neuroendocrine gastrointestinal tumors].
Eriksson B; Janson ET; Skogseid B; Oberg K
Lakartidningen; 1990 Aug; 87(35):2668-72. PubMed ID: 2214974
[No Abstract] [Full Text] [Related]
7. [Antineoplastic chemotherapy of digestive tumors].
Espinosa Arranz E; Ordóñez Gallego A; González Barón M
Med Clin (Barc); 1991 Mar; 96(12):471-4. PubMed ID: 2056788
[No Abstract] [Full Text] [Related]
8. The use of chemotherapy in the management of neuroendocrine tumors.
Oberg K
Endocrinol Metab Clin North Am; 1993 Dec; 22(4):941-52. PubMed ID: 8125079
[TBL] [Abstract][Full Text] [Related]
9. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
Lang A; Graeven U
Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
[No Abstract] [Full Text] [Related]
10. Endocrine tumors.
Lamberts SW
Cancer Chemother Biol Response Modif; 1999; 18():388-93. PubMed ID: 10800494
[No Abstract] [Full Text] [Related]
11. Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives.
Capurso G; Fazio N; Festa S; Panzuto F; De Braud F; Delle Fave G
Crit Rev Oncol Hematol; 2009 Nov; 72(2):110-24. PubMed ID: 19249226
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the nonsurgical treatment of upper gastrointestinal tract tumors.
Thomas AL; Steward WP
Expert Rev Anticancer Ther; 2001 Aug; 1(2):258-68. PubMed ID: 12113031
[TBL] [Abstract][Full Text] [Related]
13. The role of somatostatin analogs in the management of carcinoid tumors.
Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R
J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219
[No Abstract] [Full Text] [Related]
14. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors.
Shah MH; Young D; Kindler HL; Webb I; Kleiber B; Wright J; Grever M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6111-8. PubMed ID: 15447997
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic advances in digestive oncology. III. Chemotherapy of digestive system cancers].
Zeitoun P; Martin F; Nasca S
Med Chir Dig; 1979; 8(7):655-60. PubMed ID: 94142
[No Abstract] [Full Text] [Related]
16. Gastrointestinal endocrine tumors: diagnosis and management. Role of somatostatin analogue SMS 201-995. July 4-6, 1986, Vancouver, British Columbia. Proceedings.
Am J Med; 1987 May; 82(5B):1-99. PubMed ID: 2884875
[No Abstract] [Full Text] [Related]
17. Chemotherapy of endocrine malignancies: a review.
Kvols LK; Buck M
Semin Oncol; 1987 Sep; 14(3):343-53. PubMed ID: 2820064
[No Abstract] [Full Text] [Related]
18. [Targeted therapies in digestive oncology].
Boutayeb S; Bensouda Y; Fadoulkhair Z; Bakkraoui K; Bachouchi M; Errihani H
Pathol Biol (Paris); 2012 Aug; 60(4):264-8. PubMed ID: 22743093
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid tumors].
Tóth M; Prónai L; Németh AM; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
[TBL] [Abstract][Full Text] [Related]
20. [Is it possible to predict the response of digestive cancers to chemotherapy?].
Ballet F
Gastroenterol Clin Biol; 1983 Apr; 7(4):370-3. PubMed ID: 6873548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
